[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Peptide Therapeutics Market Report 2020, Forecast to 2025

February 2020 | 138 pages | ID: G2D00F95D948EN
WKinformation

US$ 3,360.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

The report forecast global Peptide Therapeutics market to grow to reach xx Million USD in 2020 with a CAGR of xx% during the period 2020-2025. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on vendors' revenue. Estimates of the regional markets for Peptide Therapeutics are based on the applications market.

The report offers detailed coverage of Peptide Therapeutics industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Peptide Therapeutics by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Peptide Therapeutics market are discussed.

The market is segmented by types:
  • Injection
  • Oral
  • Other
It can be also divided by applications:
  • Cancer
  • Metabolic Disorders
  • Central Nervous System
  • Other
And this report covers the historical situation, present status and the future prospects of the global Peptide Therapeutics market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.
  • Sanofi
  • Eli Lilly
  • Novo Nordisk
  • Takeda
  • Teva
  • Novartis
  • AstraZeneca
  • Ipsen
  • AbbVie
  • Allergan
  • Ferring
  • Merck
  • J & J
  • The Medicines
Report Includes:
  • xx data tables and xx additional tables
  • An overview of global Peptide Therapeutics market
  • An detailed key players analysis across regions
  • Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
  • Insights into regulatory and environmental developments
  • Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Peptide Therapeutics market
            • Profiles of major players in the industry, including Sanofi, Eli Lilly, Novo Nordisk, Takeda, Teva.....
Research objectives
  • To study and analyze the global Peptide Therapeutics consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
  • To understand the structure of Peptide Therapeutics market by identifying its various subsegments.
  • Focuses on the key global Peptide Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
  • To analyze the Peptide Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the consumption of Peptide Therapeutics submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
Global Peptide Therapeutics Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Peptide Therapeutics Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 PEPTIDE THERAPEUTICS INDUSTRY OVERVIEW

2.1 Global Peptide Therapeutics Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Peptide Therapeutics Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 Injection
  2.2.2 Oral
  2.2.3 Other
  2.3.2 Metabolic Disorders
  2.3.3 Central Nervous System
  2.3.4 Other
  2.4.2 Global Peptide Therapeutics Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Peptide Therapeutics Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Peptide Therapeutics Manufacturer Market Share
  2.4.5 Top 10 Peptide Therapeutics Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Peptide Therapeutics Market
  2.4.7 Key Manufacturers Peptide Therapeutics Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Peptide Therapeutics Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis

3 RELATED MARKET ANALYSIS

3.1 Related Market Overview
3.2 Macro Analysis of Upstream Markets
3.3 Key Players in Related Markets
3.4 Related Markets Trend Analysis

4 GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE CATEGORIZED BY REGIONS

4.1 Global Peptide Therapeutics Revenue and Market Share by Regions
  4.1.1 Global Peptide Therapeutics Sales and Market Share by Regions (2015-2020)
  4.1.2 Global Peptide Therapeutics Revenue and Market Share by Regions (2015-2020)
4.2 Europe Peptide Therapeutics Revenue and Growth Rate (2015-2020)
4.3 APAC Peptide Therapeutics Revenue and Growth Rate (2015-2020)
4.4 North America Peptide Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Peptide Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Peptide Therapeutics Revenue and Growth Rate (2015-2020)

5 EUROPE PEPTIDE THERAPEUTICS MARKET SIZE CATEGORIZED BY COUNTRIES

5.1 Europe Peptide Therapeutics Revenue and Market Share by Countries
  5.1.1 Europe Peptide Therapeutics Revenue by Countries (2015-2020)
  5.1.2 Germany Peptide Therapeutics Revenue and Growth Rate (2015-2020)
  5.1.3 UK Peptide Therapeutics Revenue and Growth Rate (2015-2020)
  5.1.4 France Peptide Therapeutics Revenue and Growth Rate (2015-2020)
  5.1.5 Russia Peptide Therapeutics Revenue and Growth Rate (2015-2020)
  5.1.6 Italy Peptide Therapeutics Revenue and Growth Rate (2015-2020)
  5.1.7 Spain Peptide Therapeutics Revenue and Growth Rate (2015-2020)
5.2 Europe Peptide Therapeutics Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Peptide Therapeutics Revenue and Market Share by Type (2015-2020)
5.4 Europe Peptide Therapeutics Revenue and Market Share by Application (2015-2020)

6 ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE CATEGORIZED BY COUNTRIES

6.1 Asia-Pacific Peptide Therapeutics Revenue and Market Share by Countries
  6.1.1 Asia-Pacific Peptide Therapeutics Revenue by Countries (2015-2020)
  6.1.2 China Peptide Therapeutics Revenue and Growth Rate (2015-2020)
  6.1.3 Japan Peptide Therapeutics Revenue and Growth Rate (2015-2020)
  6.1.4 Korea Peptide Therapeutics Revenue and Growth Rate (2015-2020)
  6.1.5 India Peptide Therapeutics Revenue and Growth Rate (2015-2020)
  6.1.6 Southeast Asia Peptide Therapeutics Revenue and Growth Rate (2015-2020)
  6.1.7 Australia Peptide Therapeutics Revenue and Growth Rate (2015-2020)
6.2 Asia-Pacific Peptide Therapeutics Revenue (Value) by Players (2018-2020)
6.3 Asia-Pacific Peptide Therapeutics Revenue and Market Share by Type (2015-2020)
6.4 Asia-Pacific Peptide Therapeutics Revenue and Market Share by Application (2015-2020)

7 NORTH AMERICA PEPTIDE THERAPEUTICS MARKET SIZE CATEGORIZED BY COUNTRIES

7.1 North America Peptide Therapeutics Revenue and Market Share by Countries
  7.1.1 North America Peptide Therapeutics Revenue by Countries (2015-2020)
  7.1.2 United States Peptide Therapeutics Revenue and Growth Rate (2015-2020)
  7.1.3 Canada Peptide Therapeutics Revenue and Growth Rate (2015-2020)
  7.1.4 Mexico Peptide Therapeutics Revenue and Growth Rate (2015-2020)
7.2 North America Peptide Therapeutics Revenue (Value) by Players (2018-2020)
7.3 North America Peptide Therapeutics Revenue and Market Share by Type (2015-2020)
7.4 North America Peptide Therapeutics Revenue and Market Share by Application (2015-2020)

8 SOUTH AMERICA PEPTIDE THERAPEUTICS MARKET SIZE CATEGORIZED BY COUNTRIES

8.1 South America Peptide Therapeutics Revenue and Market Share by Countries
  8.1.1 South America Peptide Therapeutics Revenue by Countries (2015-2020)
  8.1.2 Brazil Peptide Therapeutics Revenue and Growth Rate (2015-2020)
8.2 South America Peptide Therapeutics Revenue (Value) by Players (2018-2020)
8.3 South America Peptide Therapeutics Revenue and Market Share by Type (2015-2020)
8.4 South America Peptide Therapeutics Revenue and Market Share by Application (2015-2020)

9 MIDDLE EAST AND AFRICA PEPTIDE THERAPEUTICS MARKET SIZE CATEGORIZED BY COUNTRIES

9.1 Middle East and Africa Peptide Therapeutics Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Peptide Therapeutics Revenue by Countries (2015-2020)
  9.1.2 GCC Countries Peptide Therapeutics Revenue and Growth Rate (2015-2020)
  9.1.3 Turkey Peptide Therapeutics Revenue and Growth Rate (2015-2020)
  9.1.4 Egypt Peptide Therapeutics Revenue and Growth Rate (2015-2020)
  9.1.5 South Africa Peptide Therapeutics Revenue and Growth Rate (2015-2020)
9.2 Middle East and Africa Peptide Therapeutics Revenue (Value) by Players (2018-2020)
9.3 Middle East and Africa Peptide Therapeutics Revenue and Market Share by Type (2015-2020)
9.4 Middle East and Africa Peptide Therapeutics Revenue and Market Share by Application (2015-2020)

10 GLOBAL PEPTIDE THERAPEUTICS MARKET SEGMENT BY TYPE

10.1 Global Peptide Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Peptide Therapeutics Market Forecast by Type (2020-2025)
10.3 Injection Revenue Growth Rate
10.4 Oral Revenue Growth Rate
10.5 Other Revenue Growth Rate
11.1 Global Peptide Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Global Peptide Therapeutics Market Forecast by Application (2020-2025)
11.3 Cancer Revenue Growth Rate (2015-2025)
11.4 Metabolic Disorders Revenue Growth Rate (2015-2025)
11.5 Central Nervous System Revenue Growth Rate (2015-2025)
11.6 Other Revenue Growth Rate (2015-2025)
12.1 Global Peptide Therapeutics Market Size Forecast (2020-2025)
12.2 Peptide Therapeutics Market Forecast by Regions (2020-2025)
12.3 Europe Peptide Therapeutics Revenue Market Forecast (2020-2025)
12.4 APAC Peptide Therapeutics Revenue Market Forecast (2020-2025)
12.5 North America Peptide Therapeutics Revenue Market Forecast (2020-2025)
12.6 South America Peptide Therapeutics Revenue Market Forecast (2020-2025)
12.7 Middle East & Africa Peptide Therapeutics Revenue Market Forecast (2020-2025)

13 ANALYSIS OF PEPTIDE THERAPEUTICS INDUSTRY KEY VENDORS

13.1 Sanofi
  13.1.1 Company Details
  13.1.2 Product Information
  13.1.3 Sanofi Peptide Therapeutics Revenue and Gross Margin (2018-2020)
  13.1.4 Main Business Overview
  13.1.5 Sanofi News
13.2 Eli Lilly
  13.2.1 Company Details
  13.2.2 Product Information
  13.2.3 Eli Lilly Peptide Therapeutics Revenue and Gross Margin (2018-2020)
  13.2.4 Main Business Overview
  13.2.5 Eli Lilly News
13.3 Novo Nordisk
  13.3.1 Company Details
  13.3.2 Product Information
  13.3.3 Novo Nordisk Peptide Therapeutics Revenue and Gross Margin (2018-2020)
  13.3.4 Main Business Overview
  13.3.5 Novo Nordisk News
13.4 Takeda
  13.4.1 Company Details
  13.4.2 Product Information
  13.4.3 Takeda Peptide Therapeutics Revenue and Gross Margin (2018-2020)
  13.4.4 Main Business Overview
  13.4.5 Takeda News
13.5 Teva
  13.5.1 Company Details
  13.5.2 Product Information
  13.5.3 Teva Peptide Therapeutics Revenue and Gross Margin (2018-2020)
  13.5.4 Main Business Overview
  13.5.5 Teva News
13.6 Novartis
  13.6.1 Company Details
  13.6.2 Product Information
  13.6.3 Novartis Peptide Therapeutics Revenue and Gross Margin (2018-2020)
  13.6.4 Main Business Overview
  13.6.5 Novartis News
13.7 AstraZeneca
  13.7.1 Company Details
  13.7.2 Product Information
  13.7.3 AstraZeneca Peptide Therapeutics Revenue and Gross Margin (2018-2020)
  13.7.4 Main Business Overview
  13.7.5 AstraZeneca News
13.8 Ipsen
  13.8.1 Company Details
  13.8.2 Product Information
  13.8.3 Ipsen Peptide Therapeutics Revenue and Gross Margin (2018-2020)
  13.8.4 Main Business Overview
  13.8.5 Ipsen News
13.9 AbbVie
  13.9.1 Company Details
  13.9.2 Product Information
  13.9.3 AbbVie Peptide Therapeutics Revenue and Gross Margin (2018-2020)
  13.9.4 Main Business Overview
  13.9.5 AbbVie News
13.10 Allergan
  13.10.1 Company Details
  13.10.2 Product Information
  13.10.3 Allergan Peptide Therapeutics Revenue and Gross Margin (2018-2020)
  13.10.4 Main Business Overview
  13.10.5 Allergan News
13.11 Ferring
  13.11.1 Company Details
  13.11.2 Product Information
  13.11.3 Ferring Peptide Therapeutics Revenue and Gross Margin (2018-2020)
  13.11.4 Main Business Overview
  13.11.5 Ferring News
13.12 Merck
  13.12.1 Company Details
  13.12.2 Product Information
  13.12.3 Merck Peptide Therapeutics Revenue and Gross Margin (2018-2020)
  13.12.4 Main Business Overview
  13.12.5 Merck News
13.13 J & J
  13.13.1 Company Details
  13.13.2 Product Information
  13.13.3 J & J Peptide Therapeutics Revenue and Gross Margin (2018-2020)
  13.13.4 Main Business Overview
  13.13.5 J & J News
13.14 The Medicines
  13.14.1 Company Details
  13.14.2 Product Information
  13.14.3 The Medicines Peptide Therapeutics Revenue and Gross Margin (2018-2020)
  13.14.4 Main Business Overview
  13.14.5 The Medicines News

15 APPENDIX
LIST OF TABLES AND FIGURES

Figure Peptide Therapeutics Picture
Figure Research Programs/Design for This Report
Figure Global Peptide Therapeutics Market by Regions (2019)
Table Global Market Peptide Therapeutics Comparison by Regions (M USD) 2019-2025
Table Global Peptide Therapeutics Value Growth (CAGR) (2019-2025) by Type
Figure Global Value Market Share of Peptide Therapeutics by Type in 2019
Figure Injection Picture
Figure Oral Picture
Figure Other Picture
Figure Cancer Picture
Figure Metabolic Disorders Picture
Figure Central Nervous System Picture
Figure Other Picture
Table Global Peptide Therapeutics Vendors Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Peptide Therapeutics Vendors (Revenue) Market Share in 2019
Figure Top 10 Peptide Therapeutics Vendors (Revenue) Market Share in 2019
Table Date of Key Vendors Enter into Peptide Therapeutics Market
Table Key Vendors Peptide Therapeutics Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Related Markets
Figure Global Peptide Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Table Global Peptide Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table Global Peptide Therapeutics Revenue Market Share by Regions (2015-2020)
Figure Global Peptide Therapeutics Revenue Market Share by Regions in 2019
Figure Europe Peptide Therapeutics Revenue and Growth Rate (2015-2020)
Figure APAC Peptide Therapeutics Revenue and Growth Rate (2015-2020)
Figure North America Peptide Therapeutics Revenue and Growth Rate (2015-2020)
Figure South America Peptide Therapeutics Revenue and Growth Rate (2015-2020)
Figure Middle East & Africa Peptide Therapeutics Revenue and Growth Rate (2015-2020)
Figure Europe Peptide Therapeutics Revenue and Growth Rate (2015-2020)
Table Europe Peptide Therapeutics Revenue by Countries (2015-2020)
Table Europe Peptide Therapeutics Revenue Market Share by Countries (2015-2020)
Figure Europe Peptide Therapeutics Revenue Market Share by Countries in 2019
Figure Germany Peptide Therapeutics Revenue and Growth Rate (2015-2020)
Figure UK Peptide Therapeutics Revenue and Growth Rate (2015-2020)
Figure France Peptide Therapeutics Revenue and Growth Rate (2015-2020)
Figure Russia Peptide Therapeutics Revenue and Growth Rate (2015-2020)
Figure Italy Peptide Therapeutics Revenue and Growth Rate (2015-2020)
Figure Spain Peptide Therapeutics Revenue and Growth Rate (2015-2020)
Table Europe Peptide Therapeutics Revenue by Player (2018-2020)
Figure Europe Peptide Therapeutics Revenue Market Share by Player in 2019
Table Europe Peptide Therapeutics Revenue by Type (2015-2020)
Table Europe Peptide Therapeutics Revenue Share by Type (2015-2020)
Table Europe Peptide Therapeutics Revenue by Application (2015-2020)
Table Europe Peptide Therapeutics Revenue Share by Application (2015-2020)
Figure Asia-Pacific Peptide Therapeutics Revenue and Growth Rate (2015-2020)
Table Asia-Pacific Peptide Therapeutics Revenue by Countries (2015-2020)
Table Asia-Pacific Peptide Therapeutics Revenue Market Share by Countries (2015-2020)
Figure Asia-Pacific Peptide Therapeutics Revenue Market Share by Countries (2015-2020)
Figure Asia-Pacific 138 Revenue Market Share by Countries in 2019
Figure China Peptide Therapeutics Revenue and Growth Rate (2015-2020)
Figure Japan Peptide Therapeutics Revenue and Growth Rate (2015-2020)
Figure Korea Peptide Therapeutics Revenue and Growth Rate (2015-2020)
Figure India Peptide Therapeutics Revenue and Growth Rate (2015-2020)
Figure Australia Peptide Therapeutics Revenue and Growth Rate (2015-2020)
Table Asia-Pacific Peptide Therapeutics Revenue by Player (2018-2020)
Figure Asia-Pacific Peptide Therapeutics Revenue Market Share by Player in 2019
Table Asia-Pacific Peptide Therapeutics Revenue by Type (2015-2020)
Table Asia-Pacific Peptide Therapeutics Revenue Share by Type (2015-2020)
Table Asia-Pacific Peptide Therapeutics Revenue by Application (2015-2020)
Table Asia-Pacific Peptide Therapeutics Revenue Share by Application (2015-2020)
Figure North America Peptide Therapeutics Revenue and Growth Rate (2015-2020)
Table North America Peptide Therapeutics Revenue by Countries (2015-2020)
Table North America Peptide Therapeutics Revenue Market Share by Countries (2015-2020)
Figure North America Peptide Therapeutics Revenue Market Share by Countries in 2019
Figure United States Peptide Therapeutics Revenue and Growth Rate (2015-2020)
Figure Canada Peptide Therapeutics Revenue and Growth Rate (2015-2020)
Figure Mexico Peptide Therapeutics Revenue and Growth Rate (2015-2020)
Table North America Peptide Therapeutics Revenue by Player (2018-2020)
Figure North America Peptide Therapeutics Revenue Market Share by Player in 2019
Table North America Peptide Therapeutics Revenue by Type (2015-2020)
Table North America Peptide Therapeutics Revenue Share by Type (2015-2020)
Table North America Peptide Therapeutics Revenue by Application (2015-2020)
Table North America Peptide Therapeutics Revenue Share by Application (2015-2020)
Figure South America Peptide Therapeutics Revenue and Growth Rate (2015-2020)
Table South America Peptide Therapeutics Revenue by Countries (2015-2020)
Table South America Peptide Therapeutics Revenue Market Share by Countries (2015-2020)
Figure South America Peptide Therapeutics Revenue Market Share by Countries in 2019
Figure Brazil Peptide Therapeutics Revenue and Growth Rate (2015-2020)
Table South America Peptide Therapeutics Revenue by Player (2018-2020)
Figure South America Peptide Therapeutics Revenue Market Share by Manufacturer in 2019
Table South America Peptide Therapeutics Revenue by Type (2015-2020)
Table South America Peptide Therapeutics Revenue Share by Type (2015-2020)
Table South America Peptide Therapeutics Revenue by Application (2015-2020)
Table South America Peptide Therapeutics Revenue Share by Application (2015-2020)
Figure Middle East and Africa Peptide Therapeutics Revenue and Growth Rate (2015-2020)
Table Middle East and Africa Peptide Therapeutics Revenue by Countries (2015-2020)
Table Middle East and Africa Peptide Therapeutics Revenue Market Share by Countries (2015-2020)
Figure Middle East and Africa Peptide Therapeutics Sales Market Share by Countries in 2019
Figure Middle East and Africa Peptide Therapeutics Revenue Market Share by Countries in 2019
Figure GCC Countries Peptide Therapeutics Revenue and Growth Rate (2015-2020)
Figure Egypt Peptide Therapeutics Revenue and Growth Rate (2015-2020)
Figure Turkey Peptide Therapeutics Revenue and Growth Rate (2015-2020)
Figure South Africa Peptide Therapeutics Revenue and Growth Rate (2015-2020)
Table Middle East and Africa Peptide Therapeutics Revenue by Player (2018-2020)
Figure Middle East and Africa Peptide Therapeutics Revenue Market Share by Player in 2019
Table Middle East and Africa Peptide Therapeutics Revenue by Type (2015-2020)
Table Middle East and Africa Peptide Therapeutics Revenue Share by Type (2015-2020)
Table Middle East and Africa Peptide Therapeutics Revenue by Application (2015-2020)
Table Middle East and Africa Peptide Therapeutics Revenue Share by Application (2015-2020)
Table Global Peptide Therapeutics Revenue (Million USD) by Type (2015-2020)
Table Global Peptide Therapeutics Revenue Share by Type (2015-2020)
Figure Global Peptide Therapeutics Revenue Share by Type (2015-2020)
Figure Global Peptide Therapeutics Revenue Share by Type in 2019
Table Global Peptide Therapeutics Revenue Forecast by Type (2020-2025)
Figure Global Peptide Therapeutics Market Share Forecast by Type (2020-2025)
Figure Global Injection Revenue Growth Rate (2015-2025)
Figure Global Oral Revenue Growth Rate (2015-2025)
Figure Global Other Revenue Growth Rate (2015-2025)
Figure Global Peptide Therapeutics Revenue Share by Application (2015-2020)
Figure Global Peptide Therapeutics Revenue Share by Application in 2019
Figure Global Peptide Therapeutics Revenue Forecast by Application (2020-2025)
Figure Global Peptide Therapeutics Market Share Forecast by Application (2020-2025)
Figure Global Cancer Revenue Growth Rate (2015-2025)
Figure Global Metabolic Disorders Revenue Growth Rate (2015-2025)
Figure Global Central Nervous System Revenue Growth Rate (2015-2025)
Figure Global Other Revenue Growth Rate (2015-2025)
Figure Global Peptide Therapeutics Revenue Market Share Forecast by Regions (2020-2025)
Figure Europe Peptide Therapeutics Revenue Market Forecast (2020-2025)
Figure Asia-Pacific Peptide Therapeutics Revenue Market Forecast (2020-2025)
Figure North America Peptide Therapeutics Revenue Market Forecast (2020-2025)
Figure South America Peptide Therapeutics Revenue Market Forecast (2020-2025)
Figure Middle East and Africa Peptide Therapeutics Revenue Market Forecast (2020-2025)
Table Sanofi Company Profile
Figure Peptide Therapeutics Product Picture and Specifications of Sanofi
Table Peptide Therapeutics Revenue (M USD) and Gross Margin 2018-2020
Figure Sanofi Peptide Therapeutics Market Share (2018-2020)
Table Sanofi Main Business
Table Sanofi Recent Development
Table Eli Lilly Company Profile
Figure Peptide Therapeutics Product Picture and Specifications of Eli Lilly
Table Peptide Therapeutics Revenue (M USD) and Gross Margin 2018-2020
Figure Eli Lilly Peptide Therapeutics Market Share (2018-2020)
Table Eli Lilly Main Business
Table Eli Lilly Recent Development
Table Novo Nordisk Company Profile
Figure Peptide Therapeutics Product Picture and Specifications of Novo Nordisk
Table Peptide Therapeutics Revenue (M USD) and Gross Margin 2018-2020
Figure Novo Nordisk Peptide Therapeutics Market Share (2018-2020)
Table Novo Nordisk Main Business
Table Novo Nordisk Recent Development
Table Takeda Company Profile
Figure Peptide Therapeutics Product Picture and Specifications of Takeda
Table Peptide Therapeutics Revenue (M USD) and Gross Margin 2018-2020
Figure Takeda Peptide Therapeutics Market Share (2018-2020)
Table Takeda Main Business
Table Takeda Recent Development
Table Teva Company Profile
Figure Peptide Therapeutics Product Picture and Specifications of Teva
Table Peptide Therapeutics Revenue (M USD) and Gross Margin 2018-2020
Figure Teva Peptide Therapeutics Market Share (2018-2020)
Table Teva Main Business
Table Teva Recent Development
Table Novartis Company Profile
Figure Peptide Therapeutics Product Picture and Specifications of Novartis
Table Peptide Therapeutics Revenue (M USD) and Gross Margin 2018-2020
Figure Novartis Peptide Therapeutics Market Share (2018-2020)
Table Novartis Main Business
Table Novartis Recent Development
Table AstraZeneca Company Profile
Figure Peptide Therapeutics Product Picture and Specifications of AstraZeneca
Table Peptide Therapeutics Revenue (M USD) and Gross Margin 2018-2020
Figure AstraZeneca Peptide Therapeutics Market Share (2018-2020)
Table AstraZeneca Main Business
Table AstraZeneca Recent Development
Table Ipsen Company Profile
Figure Peptide Therapeutics Product Picture and Specifications of Ipsen
Table Peptide Therapeutics Revenue (M USD) and Gross Margin 2018-2020
Figure Ipsen Peptide Therapeutics Market Share (2018-2020)
Table Ipsen Main Business
Table Ipsen Recent Development
Table AbbVie Company Profile
Figure Peptide Therapeutics Product Picture and Specifications of AbbVie
Table Peptide Therapeutics Revenue (M USD) and Gross Margin 2018-2020
Figure AbbVie Peptide Therapeutics Market Share (2018-2020)
Table AbbVie Main Business
Table AbbVie Recent Development
Table Allergan Company Profile
Figure Peptide Therapeutics Product Picture and Specifications of Allergan
Table Peptide Therapeutics Revenue (M USD) and Gross Margin 2018-2020
Figure Allergan Peptide Therapeutics Market Share (2018-2020)
Table Allergan Main Business
Table Allergan Recent Development
Table Ferring Company Profile
Figure Peptide Therapeutics Product Picture and Specifications of Ferring
Table Peptide Therapeutics Revenue (M USD) and Gross Margin 2018-2020
Figure Ferring Peptide Therapeutics Market Share (2018-2020)
Table Ferring Main Business
Table Ferring Recent Development
Table Merck Company Profile
Figure Peptide Therapeutics Product Picture and Specifications of Merck
Table Peptide Therapeutics Revenue (M USD) and Gross Margin 2018-2020
Figure Merck Peptide Therapeutics Market Share (2018-2020)
Table Merck Main Business
Table Merck Recent Development
Table J & J Company Profile
Figure Peptide Therapeutics Product Picture and Specifications of J & J
Table Peptide Therapeutics Revenue (M USD) and Gross Margin 2018-2020
Figure J & J Peptide Therapeutics Market Share (2018-2020)
Table J & J Main Business
Table J & J Recent Development
Table The Medicines Company Profile
Figure Peptide Therapeutics Product Picture and Specifications of The Medicines
Table Peptide Therapeutics Revenue (M USD) and Gross Margin 2018-2020
Figure The Medicines Peptide Therapeutics Market Share (2018-2020)
Table The Medicines Main Business
Table The Medicines Recent Development


More Publications